Study of Sting Challenge and Serological Responses to Jack Jumper Venom Immunotherapy With Inulin as Adjuvant (Jumpvax)

NCT03066986 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER_GOV

Sponsor class

Conditions

Ant Sting
Immunotherapy

Interventions

DRUG: Delta-inulin
BIOLOGICAL: Dose finding comparison

Sponsor

Central Adelaide Local Health Network Incorporated

Collaborators

[object Object]